Literature DB >> 34350622

Patient-reported neurocognitive symptoms influence instrumental activities of daily living in sickle cell disease.

Jennifer N Longoria1, Norma L Pugh2, Victor Gordeuk3, Lewis L Hsu4, Marsha Treadwell5, Allison A King6, Robert Gibson7, Mariam Kayle8, Nancy Crego9, Jeffrey Glassberg10, Cathy L Melvin11, Jane S Hankins12, Jerlym Porter1.   

Abstract

Individuals with sickle cell disease (SCD) experience neurocognitive decline, low medication adherence, increased unemployment, and difficulty with instrumental activities of daily living (IADL). The relationship between self-perceived cognitive difficulties and IADLs, including employment, school enrollment, independence, engagement in leisure activities, and medication adherence is unknown. We hypothesized that self-reported difficulties across neurocognitive areas would predict lower IADL skills. Adolescent and adult participants of the multi-site Sickle Cell Disease Implementation Consortium (SCDIC) (n = 2436) completed patient-reported outcome (PRO) measures of attention, executive functioning, processing speed, learning, and comprehension. Cognitive symptoms were analyzed as predictors in multivariable modeling. Outcome variables included 1) an IADL composite that consisted of employment, participation in school, reliance on others, and leisure pursuits, and 2) hydroxyurea adherence. Participants reported cognitive difficulty across areas of attention (55%), executive functioning (51%), processing speed (57%), and reading comprehension (65%). Executive dysfunction (p < 0.001) and sometimes or often experiencing learning difficulties (p < 0.001 and p = 0.04) and poor comprehension (p = 0.000 and p = 0.001), controlled for age (p < 0.001), pain (p < 0.001), and hydroxyurea use (p = 0.001), were associated with poor IADL skills. Executive functioning difficulties (p = 0.021), controlled for age (p = 0.013 for ages 25-34), genotype (p = 0.001), and hemoglobin (p = 0.004), predicted hydroxyurea non-adherence. Analysis of PRO measures indicated that cognitive dysfunction is prevalent in adolescents and adults with SCD. Cognitive dysfunction translated into clinically meaningful outcomes. PRO of cognitive symptoms can be used as an important adjunct clinical tool to monitor symptoms that impact functional skills, including engagement in societal activities and medication adherence.
© 2021 Wiley Periodicals LLC.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34350622      PMCID: PMC8855994          DOI: 10.1002/ajh.26315

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  27 in total

1.  Mapping continued brain growth and gray matter density reduction in dorsal frontal cortex: Inverse relationships during postadolescent brain maturation.

Authors:  E R Sowell; P M Thompson; K D Tessner; A W Toga
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

Review 2.  Managing sickle cell disease.

Authors:  Susan Claster; Elliott P Vichinsky
Journal:  BMJ       Date:  2003-11-15

3.  Cognitive deficits are associated with unemployment in adults with sickle cell anemia.

Authors:  Maureen Sanger; Lori Jordan; Sumit Pruthi; Matthew Day; Brittany Covert; Brenda Merriweather; Mark Rodeghier; Michael DeBaun; Adetola Kassim
Journal:  J Clin Exp Neuropsychol       Date:  2016-08       Impact factor: 2.475

4.  Transition Needs of Adolescents With Sickle Cell Disease.

Authors:  Regina A Abel; Esther Cho; Kelley R Chadwick-Mansker; Natalia D'Souza; Ashley J Housten; Allison A King
Journal:  Am J Occup Ther       Date:  2015 Mar-Apr

5.  Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia.

Authors:  Elliott P Vichinsky; Lynne D Neumayr; Jeffrey I Gold; Michael W Weiner; Randall R Rule; Diana Truran; Jeffrey Kasten; Barry Eggleston; Karen Kesler; Lillian McMahon; Eugene P Orringer; Thomas Harrington; Karen Kalinyak; Laura M De Castro; Abdullah Kutlar; Cynthia J Rutherford; Cage Johnson; Joel David Bessman; Lanetta B Jordan; F Daniel Armstrong
Journal:  JAMA       Date:  2010-05-12       Impact factor: 56.272

6.  Cognitive Function in Sickle Cell Disease Across Domains, Cerebral Infarct Status, and the Lifespan: A Meta-Analysis.

Authors:  Kemar V Prussien; Lori C Jordan; Michael R DeBaun; Bruce E Compas
Journal:  J Pediatr Psychol       Date:  2019-09-01

Review 7.  Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.

Authors:  Barbara P Yawn; George R Buchanan; Araba N Afenyi-Annan; Samir K Ballas; Kathryn L Hassell; Andra H James; Lanetta Jordan; Sophie M Lanzkron; Richard Lottenberg; William J Savage; Paula J Tanabe; Russell E Ware; M Hassan Murad; Jonathan C Goldsmith; Eduardo Ortiz; Robinson Fulwood; Ann Horton; Joylene John-Sowah
Journal:  JAMA       Date:  2014-09-10       Impact factor: 56.272

Review 8.  Incorporating Patient-Reported Outcomes Into Health Care To Engage Patients And Enhance Care.

Authors:  Danielle C Lavallee; Kate E Chenok; Rebecca M Love; Carolyn Petersen; Erin Holve; Courtney D Segal; Patricia D Franklin
Journal:  Health Aff (Millwood)       Date:  2016-04       Impact factor: 6.301

9.  Integration of Mobile Health Into Sickle Cell Disease Care to Increase Hydroxyurea Utilization: Efficacy and Implementation Study.

Authors:  Jane S Hankins; Nirmish Shah; Lisa DiMartino; Donald Brambrilla; Maria E Fernandez; Robert W Gibson; Victor R Gordeuk; Richard Lottenberg; Abdullah Kutlar; Cathy Melvin; Jena Simon; Ted Wun; Marsha Treadwell; Cecelia Calhoun; Ana Baumann; Michael B Potter; Lisa Klesges; Hayden Bosworth
Journal:  JMIR Res Protoc       Date:  2020-04-07

10.  Prevalence and predictors of chronic pain intensity and disability among adults with sickle cell disease.

Authors:  Nadine Matthie; Coretta Jenerette; Ashley Gibson; Sudeshna Paul; Melinda Higgins; Lakshmanan Krishnamurti
Journal:  Health Psychol Open       Date:  2020-04-28
View more
  3 in total

Review 1.  Testosterone Deficiency in Sickle Cell Disease: Recognition and Remediation.

Authors:  Biljana Musicki; Arthur L Burnett
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-03       Impact factor: 6.055

Review 2.  Cognitive Impairment in Primary and Secondary Headache Disorders.

Authors:  Olivia Begasse de Dhaem; Matthew S Robbins
Journal:  Curr Pain Headache Rep       Date:  2022-03-03

3.  Chronic Pain Treatment and Digital Health Era-An Opinion.

Authors:  V Rejula; J Anitha; R V Belfin; J Dinesh Peter
Journal:  Front Public Health       Date:  2021-12-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.